Health & Fitness
Health and Fitness
Health and Fitness 
Wed, April 6, 2011
Tue, April 5, 2011
Mon, April 4, 2011
Sun, April 3, 2011
Sat, April 2, 2011
Fri, April 1, 2011
Thu, March 31, 2011
Wed, March 30, 2011
Tue, March 29, 2011
Mon, March 28, 2011
Sun, March 27, 2011
Fri, March 25, 2011
Thu, March 24, 2011
Wed, March 23, 2011
Tue, March 22, 2011
Mon, March 21, 2011
Sun, March 20, 2011
Fri, March 18, 2011
Thu, March 17, 2011
Wed, March 16, 2011
Response Genetics, Inc. to Release Fourth Quarter and Full-Year 2010 Financial Results and Operational Update on March 29, 2011
LOS ANGELES--([ BUSINESS WIRE ])--Response Genetics, Inc. (Nasdaq:RGDX),a company focused on the development and commercialization of molecular diagnostic tests for cancer, will announce its fourth quarter and full-year 2010 financial results and an operational update in a press release to be issued before the market opens on Tuesday, March 29, 2011.
About Response Genetics, Inc.
Response Genetics Inc. (aRGIa) is focused on the development and sale of molecular diagnostic tests for cancer. RGIa™s technologies enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin-embedded specimens. In addition to diagnostic testing services, the Company generates revenue from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry. RGI was founded in 1999 and its principal headquarters are located in Los Angeles, California. For more information, please visit [ www.responsegenetics.com ].
Forward-Looking Statement Notice
Except for the historical information contained herein, this press release and the statements of representatives of RGI related thereto contain or may contain, among other things, certain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995.
Such forward-looking statements involve significant risks and uncertainties. Such statements may include, without limitation, statements with respect to the Companya™s plans, objectives, projections, expectations and intentions, such as the ability of the Company to announce its financial statements for the fourth quarter of 2010 and full-year 2010 financial results, the ability of the Company to provide an operational update, the ability of the Company to continue to collect revenues on sales of its ResponseDX tests, and other statements identified by words such as aprojects,a amay,a acould,a awould,a ashould,a abelieves,a aexpects,a aanticipates,a aestimates,a aintends,a aplansa or similar expressions.
These statements are based upon the current beliefs and expectations of the Companya™s management and are subject to significant risks and uncertainties, including those detailed in the Companya™s filings with the Securities and Exchange Commission. Actual results, including, without limitation, actual sales results, if any, or the application of funds, may differ from those set forth in the forward-looking statements. These forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the Companya™s control). The Company undertakes no obligation to publicly update forward-looking statements, whether because of new information, future events or otherwise, except as required by law.
